Docosahexaenoic Acid (DHA) Market Analysis

  • Report ID: 3946
  • Published Date: Nov 20, 2025
  • Report Format: PDF, PPT

Docosahexaenoic Acid (DHA) Market Segmentation:

Type Segment Analysis

The algae docosahexaenoic acid market is estimated to gain around 61% market share in the coming years owing to the rising application of algae-based omega-3s in infant food. Algae oil is used as a substitute to fish in baby milk and food and is considered a primary source of omega-3 fats. It is used in formulations for newborns and young children in powder form since it is high in the omega-3 fats EPA and DHA.

In addition, more than 500 human goods now employ the omega-3 oil that comes from these algae which is also known as a vegetarian source of docosahexaenoic acid.

End-User Segment Analysis

The pregnant mothers segment in the docosahexaenoic acid market is set to garner a notable share in the near future driven by the growing demand for DHA in pregnant mothers. Pregnant women must consume sufficient levels of DHA to improve the quality of their pregnancies and the health of their fetuses. A growing body of research indicates that pregnant women may benefit from taking supplements of omega-3 fatty acids, particularly DHA, which may aid in maintaining a healthy birth weight.

Our in-depth analysis of the global market includes the following segments:

     Type

  • Fish Oil DHA

  • Algae DHA

     Form

  • Powder

  • Liquid

     Application

  • Improving memory

  • Brain development

     End-User

  • Breastfeeding Mothers

  • Infants

  • Pregnant Mothers

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of docosahexaenoic acid is assessed at USD 5.72 billion.

The global docosahexaenoic acid market size was valued at over USD 5.25 billion in 2025 and is expected to expand at a CAGR of around 9.9%, surpassing USD 13.49 billion revenue by 2035.

The Asia Pacific region is forecasted to command a 42% share by 2035 in the docosahexaenoic acid (DHA) market, impelled by escalating healthcare expenditure that is heightening awareness of DHA’s health benefits.

Key players in the market include Koninklijke DSM N.V., BASF SE, Croda International Plc, Cellana, Inc., Far East Microalgae Industries, Co., Ltd.(FEMICO), Pelagia AS, Corbion NV, JC Biotech Private Limited, Source Omega LLC, Shandong Yuexiang Biotechnology Co., Ltd.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos